Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately.
Related Posts
Noida Int’l Airport begins commercial operations; first IndiGo flight lands at Jewar
Noida International Airport commenced commercial operations today with an IndiGo flight from Lucknow, marking a significant achievement for the greenfield…
The Yamuna is rising again: How prepared is Delhi for another flood?
Delhi is under the shadow of recurrent flooding threats as the Yamuna River inches closer to its danger threshold. The…